Guidance document : certificates of supplementary protection. : H164-305/2023E-1-PDF

"In agreeing to apply the Canada-European Union Comprehensive Economic and Trade Agreement (CETA), Canada has committed to provide up to two years of sui generis (of its own kind) protection for new pharmaceutical products protected by an eligible patent, from the expiry of the patent. Canada has implemented this commitment by introducing Certificates of Supplementary Protection (CSPs) for medicinal ingredients, applicable for Canadian pharmaceuticals, biologics and veterinary drugs. … The purpose of this Guidance Document is to outline the CSP application process for applicants, the service standard and the roles and responsibilities of applicants and Health Canada"--Introduction, page 7.

Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.927743&sl=1

• Format MARC XML
• Format MARC HTML

Demander des formats alternatifs